PBM
Psyence Biomedical Ltd.
NASDAQ · Healthcare · Biotechnology · CA
$6.63
+4.83%Institutional positioning
13F filings over the trailing two quarters
New 8Increased 0Reduced 1Sold out 0
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Parallel Advisors, LLC | Unchanged | 151,250 | Aug 5, 2026 |
| PARALLEL ADVISORS, LLC | New Position | 151,250 | Jun 3, 2026 |
| AdvisorShares Investments LLC | New Position | 122,184 | Aug 11, 2026 |
| MORGAN STANLEY | New Position | 37,804 | Aug 13, 2026 |
| JANE STREET GROUP, LLC | New Position | 30,431 | Aug 14, 2026 |
| XTX Topco Ltd | New Position | 15,094 | Aug 14, 2026 |
| CITADEL ADVISORS LLC | New Position | 11,693 | Sep 2, 2026 |
| STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD | Reduced | 89 | May 13, 2026 |
| Stonehage Fleming Financial Services Holdings Ltd | Unchanged | 89 | Aug 17, 2026 |
| UBS Group AG | New Position | 60 | Aug 13, 2026 |
| Caitlin John, LLC | New Position | 35 | Aug 17, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings